United States Patent and Trademark Office (USPTO) issues U.S. patent covering an enhanced formulation of Pliaglis
Tuesday, July 16, 2019 | DrugName : Pliaglis Crescita Therapeutics Inc., a commercial dermatology company with a portfolio of non-prescription
Read More